Literature DB >> 28737018

Increased myocardial native T1 relaxation time in patients with nonischemic dilated cardiomyopathy with complex ventricular arrhythmia.

Shiro Nakamori1, An H Bui1,2, Jihye Jang1, Hossam A El-Rewaidy1, Shingo Kato1, Long H Ngo1, Mark E Josephson1,2, Warren J Manning1,3, Reza Nezafat1.   

Abstract

PURPOSE: To study the relationship between diffuse myocardial fibrosis and complex ventricular arrhythmias (ComVA) in patients with nonischemic dilated cardiomyopathy (NICM). We hypothesized that NICM patients with ComVA would have a higher native myocardial T1 time, suggesting more extensive myocardial diffuse fibrosis.
MATERIALS AND METHODS: We prospectively enrolled NICM patients with a history of ComVA (n = 50) and age-matched NICM patients without ComVA (n = 57). Imaging was performed at 1.5T with a protocol that included cine magnetic resonance imaging (MRI) for left ventricular (LV) function, late gadolinium enhancement (LGE) for focal scar, and native T1 mapping for diffuse fibrosis assessment.
RESULTS: Global native T1 time was significantly higher in patients with NICM with ComVA when compared to patients with NICM without ComVA (1131 ± 42 vs. 1107 ± 45 msec, P = 0.006), and this finding remained after excluding segments with scar on LGE (1124 ± 36 vs. 1102 ± 44 msec, P = 0.006). Native T1 was similar in NICM patients with and without the presence of LGE (1121 ± 39 vs. 1117 ± 48 msec, P = 0.68) and mildly correlated with LV end-diastolic volume index (r = 0.27, P = 0.005), LV end-systolic volume index (r = 0.24, P = 0.01), and LV ejection fraction (r = -0.28, P = 0.003). Native T1 value for each 10-msec increment was an independent predictor of ComVA (odds ratio 1.14, 95% confidence interval 1.03-1.25; P = 0.008) beyond LV function and LGE.
CONCLUSION: NICM patients with ComVA have higher native T1 compared to NICM without any documented ComVA. Native myocardial T1 is independently associated with ComVA, after adjusting for LV function and LGE. LEVEL OF EVIDENCE: 2 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2018;47:779-786. In memoriam: The authors are grateful for Dr. Josephson's inspiring guidance and contributions to this study.
© 2017 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  diffuse myocardial fibrosis. ventricular arrhythmia; native T1 mapping; nonischemic dilated cardiomyopathy

Mesh:

Substances:

Year:  2017        PMID: 28737018      PMCID: PMC5967630          DOI: 10.1002/jmri.25811

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  39 in total

Review 1.  Where genome meets phenome: rationale for integrating genetic and protein biomarkers in the diagnosis and management of dilated cardiomyopathy and heart failure.

Authors:  Sanaz Piran; Peter Liu; Ana Morales; Ray E Hershberger
Journal:  J Am Coll Cardiol       Date:  2012-07-24       Impact factor: 24.094

2.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

3.  Patients with valvular heart disease presenting with sustained ventricular tachyarrhythmias or syncope: results of programmed ventricular stimulation and long-term follow-up.

Authors:  A Martínez-Rubio; Y Schwammenthal; E Schwammenthal; M Block; L Reinhardt; A Garcia-Alberola; G Sierra; M Shenasa; W Haverkamp; H H Scheld; G Breithardt; M Borggrefe
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

4.  Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.

Authors:  G M Felker; R E Thompson; J M Hare; R H Hruban; D E Clemetson; D L Howard; K L Baughman; E K Kasper
Journal:  N Engl J Med       Date:  2000-04-13       Impact factor: 91.245

5.  Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars.

Authors:  Kyoko Soejima; William G Stevenson; John L Sapp; Andrew P Selwyn; Gregory Couper; Laurence M Epstein
Journal:  J Am Coll Cardiol       Date:  2004-05-19       Impact factor: 24.094

6.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

Authors:  Alan Kadish; Alan Dyer; James P Daubert; Rebecca Quigg; N A Mark Estes; Kelley P Anderson; Hugh Calkins; David Hoch; Jeffrey Goldberger; Alaa Shalaby; William E Sanders; Andi Schaechter; Joseph H Levine
Journal:  N Engl J Med       Date:  2004-05-20       Impact factor: 91.245

7.  Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.

Authors:  J A McCrohon; J C C Moon; S K Prasad; W J McKenna; C H Lorenz; A J S Coats; D J Pennell
Journal:  Circulation       Date:  2003-06-23       Impact factor: 29.690

8.  Re-entrant ventricular arrhythmias in the late myocardial infarction period. 1. Conduction characteristics in the infarction zone.

Authors:  N El-Sherif; B J Scherlag; R Lazzara; R R Hope
Journal:  Circulation       Date:  1977-05       Impact factor: 29.690

9.  Reproducibility of myocardial T1 and T2 relaxation time measurement using slice-interleaved T1 and T2 mapping sequences.

Authors:  Steven Bellm; Tamer A Basha; Ravi V Shah; Venkatesh L Murthy; Charlene Liew; Maxine Tang; Long H Ngo; Warren J Manning; Reza Nezafat
Journal:  J Magn Reson Imaging       Date:  2016-04-04       Impact factor: 4.813

10.  Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy.

Authors:  Valentina O Puntmann; Tobias Voigt; Zhong Chen; Manuel Mayr; Rashed Karim; Kawal Rhode; Ana Pastor; Gerald Carr-White; Reza Razavi; Tobias Schaeffter; Eike Nagel
Journal:  JACC Cardiovasc Imaging       Date:  2013-03-14
View more
  12 in total

Review 1.  Prospects of using cardiovascular magnetic resonance in the identification of arrhythmogenic substrate in autoimmune rheumatic diseases.

Authors:  Sophie I Mavrogeni; Petros P Sfikakis; Theodoros Dimitroulas; Loukia Koutsogeorgopoulou; George Markousis-Mavrogenis; George Poulos; Genovefa Kolovou; George Theodorakis; George D Kitas
Journal:  Rheumatol Int       Date:  2018-07-24       Impact factor: 2.631

Review 2.  Cardiac magnetic resonance fingerprinting: Trends in technical development and potential clinical applications.

Authors:  Brendan L Eck; Scott D Flamm; Deborah H Kwon; W H Wilson Tang; Claudia Prieto Vasquez; Nicole Seiberlich
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2020-11-06       Impact factor: 9.795

3.  Characterization of interstitial diffuse fibrosis patterns using texture analysis of myocardial native T1 mapping.

Authors:  Hossam El-Rewaidy; Ulf Neisius; Shiro Nakamori; Long Ngo; Jennifer Rodriguez; Warren J Manning; Reza Nezafat
Journal:  PLoS One       Date:  2020-06-01       Impact factor: 3.240

4.  Comparison between renal denervation and metoprolol on the susceptibility of ventricular arrhythmias in rats with myocardial infarction.

Authors:  Wanying Jiang; Chu Chen; Junyu Huo; Dasheng Lu; Zhixin Jiang; Jie Geng; Hai Xu; Qijun Shan
Journal:  Sci Rep       Date:  2018-07-05       Impact factor: 4.379

5.  Measurement reproducibility of slice-interleaved T1 and T2 mapping sequences over 20 months: A single center study.

Authors:  Jihye Jang; Long H Ngo; Gabriella Captur; James C Moon; Reza Nezafat
Journal:  PLoS One       Date:  2019-07-25       Impact factor: 3.240

6.  The impact of tissue-tracking strain on the left atrial dysfunction in the patients with left ventricular dysfunction.

Authors:  Hideki Koike; Satoru Kishi; Naoki Hosoda; Shuhei Takemoto; Daijiro Tomii; Kai Ninomiya; Tetsu Tanaka; Masahiko Asami; Kazuyuki Yahagi; Kota Komiyama; Jun Tanaka; Hitomi Yuzawa; Rine Nakanishi; Tadashi Fujino; Jiro Aoki; Bharath A Venkatesh; João A C Lima; Kengo Tanabe; Takanori Ikeda
Journal:  Int J Cardiol Heart Vasc       Date:  2020-01-05

Review 7.  The Role of AI in Characterizing the DCM Phenotype.

Authors:  Clint Asher; Esther Puyol-Antón; Maleeha Rizvi; Bram Ruijsink; Amedeo Chiribiri; Reza Razavi; Gerry Carr-White
Journal:  Front Cardiovasc Med       Date:  2021-12-21

Review 8.  CMR-Based Risk Stratification of Sudden Cardiac Death and Use of Implantable Cardioverter-Defibrillator in Non-Ischemic Cardiomyopathy.

Authors:  Laura Keil; Céleste Chevalier; Paulus Kirchhof; Stefan Blankenberg; Gunnar Lund; Kai Müllerleile; Christina Magnussen
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

9.  Left ventricular geometry predicts ventricular tachyarrhythmia in patients with left ventricular systolic dysfunction: a comprehensive cardiovascular magnetic resonance study.

Authors:  Shiro Nakamori; Haisam Ismail; Long H Ngo; Warren J Manning; Reza Nezafat
Journal:  J Cardiovasc Magn Reson       Date:  2017-10-23       Impact factor: 5.364

Review 10.  Role of CMR Imaging in Diagnostics and Evaluation of Cardiac Involvement in Muscle Dystrophies.

Authors:  Edyta Blaszczyk; Jan Gröschel; Jeanette Schulz-Menger
Journal:  Curr Heart Fail Rep       Date:  2021-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.